COVID-19: A Catalyst for Change for UK Clinical Oncology
Int J Radiat Oncol Biol Phys
.
2020 Oct 1;108(2):462-465.
doi: 10.1016/j.ijrobp.2020.06.041.
Authors
Charlotte Elizabeth Coles
1
,
Ananya Choudhury
2
,
Peter J Hoskin
3
,
Christopher M Jones
4
,
Ben O'Leary
5
,
Tom W Roques
6
,
Hannah Tharmalingam
7
,
Frances A P Yuille
8
Affiliations
1
Department of Oncology, University of Cambridge, Cambridge, UK. Electronic address:
[email protected]
.
2
The Christie NHS Foundation Trust, Manchester, UK; University of Manchester, Manchester, UK.
3
University of Manchester, Manchester, UK; Mount Vernon Cancer Centre, London, UK.
4
University of Leeds, Leeds, UK; Leeds Cancer Centre, Leeds, UK.
5
The Institute of Cancer Research and The Royal Marsden Hospital, London, UK.
6
Royal College of Radiologists, London, UK; Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.
7
Mount Vernon Cancer Centre, London, UK; Royal College of Radiologists, London, UK.
8
Royal College of Radiologists, London, UK; Edinburgh Cancer Centre, Edinburgh, UK.
PMID:
32890533
PMCID:
PMC7462794
DOI:
10.1016/j.ijrobp.2020.06.041
No abstract available
Publication types
Editorial
Comment
Grants and funding
NIHR300024/DH_/Department of Health/United Kingdom